What is the Buying Price of Novelix Pharmaceuticals Share?

The Buying Price of Novelix Pharmaceuticals share is 77.07 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

How to buy Novelix Pharmaceuticals Share at Choice?

To buy Novelix Pharmaceuticals stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Novelix Pharmaceuticals, choose your preferred order type, and place the trade.

What is the PE ratio of Novelix Pharmaceuticals Shares?

The Price-to-earnings (P/E) ratio of Novelix Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.

What is the PB ratio of Novelix Pharmaceuticals Shares?

The Price to Book (P/B) ratio Novelix Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.

Is Novelix Pharmaceuticals Overvalued?

To assess Novelix Pharmaceuticals’s valuation compare Sector P/E, P/B which are 40.03 & 2.27 with sector averages, along with growth rates and financial metrics.

What is the Market Cap of Novelix Pharmaceuticals?

The Market Cap of Novelix Pharmaceuticals is 141.29 CR. It indicates the company's size category and trading liquidity.

What is the 52 Week High and Low of Novelix Pharmaceuticals Share Price?

The 52 week high and low prices of Novelix Pharmaceuticals share price is 92 & 30.79. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Which sector does Novelix Pharmaceuticals belong to?

Novelix Pharmaceuticals belongs to the Miscellaneous sector.

Novelix Pharmaceuticals Share price

NOVELIX

Miscellaneous Small Cap

77.07

3.14 (-3.91%)

Last updated on 24 Jun, 2026 | 15:29 IST

BuySell

Today's High

83.90

Today's Low

77.00

52 Week Low

30.79

52 Week High

92.00

Novelix Pharmaceuticals Chart

ChartIQ

TradingView

Novelix Pharmaceuticals Share Key Metrics

Volume

1638.00

Market Cap

141.29 CR

LTQ@LTP

74@77.07

ATP

78.45 Var Margin

100 %

Circuit Range

76.2-84.22

Delivery %

100 %

Value

1.29 L

ASM/GSM

No

Market Lot

1

Summary

24 Jun, 2026 | 15:29 को, Novelix Pharmaceuticals का शेयर प्राइस आज ₹77.07 पर है, जो दिन के लिए 3.14% की -3.91 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹77.00 और ₹83.90 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹30.79 से ₹92.00 तक रही है। ट्रेडिंग गतिविधि के मामले में, Novelix Pharmaceuticals ने 1638 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹17615000 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹7845 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 74,7707 रही। यह स्टॉक ₹76.2-84.22 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹1.29 L है। दिन के लिए डिलीवरी परसेंटेज 100% रही। इसके अतिरिक्त, Novelix Pharmaceuticals वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Novelix Pharmaceuticals Fundamentals

P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

40.03

Sector P/B

2.27

Sec. Div. Yield

76.93

Novelix Pharmaceuticals Resistance and Support

Pivot 81.1

Resistance

First Resistance

82.59

Second Resistance

84.98

Third Resistance

86.47

Support

First Support

78.71

Second Support

77.22

Third Support

74.83

Novelix Pharmaceuticals Shareholding Pattern

2016-17
2018-19
2019-20
2020-21
2021-22
2022-23
2023-24
2024-25
2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

49.43%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

50.57%

Others

0%

Total Promoters

MAR '26

49.43%

Novelix Pharmaceuticals Corporate Actions

Date	Agenda
2026-06-04	Preferential Issue of shares & Others
2026-05-29	Audited Results & Preferential issue
2026-02-12	Quarterly Results

Novelix Pharmaceuticals News

Novelix Pharmaceuticals Ltd - 536565 - Shareholders Meeting- Corrigendum To The EGM Notice Of The EGM Scheduled To Be Held On 01St July, 2026.

Novelix Pharmaceuticals issued a corrigendum to its EGM notice for July 01, 2026. The update modifies the list of proposed allottees for the preferential issue after two individuals were disqualified for violating SEBI ICDR Regulations, leading to the re-allocation of 175,000 shares.

Jun 17 2026 17:43:09

Novelix Pharmaceuticals Ltd - 536565 - Shareholders Meeting- Notice Of Extra-Ordinary General Meeting Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.

Novelix Pharmaceuticals will convene an EGM on July 1, 2026, to obtain shareholder approval for a preferential issue of 1.2 million equity shares. The company plans to raise Rs.6.84 crores through this issue, priced at Rs.57 per share, with proceeds earmarked for lab-scale technology transfer, land lease, and pre-operative expenses.

Jun 09 2026 18:27:12

Novelix Pharmaceuticals Ltd - 536565 - Announcement under Regulation 30 (LODR)-Preferential Issue

Trimurthi's board approved a preferential issue of 1,200,000 equity shares to non-promoters, raising Rs. 6.84 crore. Each share is priced at Rs. 57, including a premium of Rs. 47, pending EGM approval.

Jun 05 2026 14:18:23

Novelix Pharmaceuticals Ltd - 536565 - Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) (LODR) Regulations, 2015

Novelix Pharmaceuticals board approved a preferential allotment of 1.2 million equity shares at ₹57 each to non-promoters, raising ₹6.84 crores. An EGM is scheduled for July 1, 2026, to obtain shareholder approval for this capital raise.

Jun 04 2026 22:44:39

Novelix Pharmaceuticals Ltd - 536565 - Announcement Under Regulation 30 (LODR) - Intimation Regarding The Execution Of An Agreement With GMBU E.V., Halle (Saale), Germany.

Novelix Pharmaceuticals signed an agreement with GMBU e.V., Germany, for the commercial scale-up of Astaxanthin production. This will take place at the company's research facilities in Hyderabad, India, after successful pilot scale production.

Jun 03 2026 15:45:14

Novelix Pharmaceuticals Ltd - 536565 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Novelix Pharmaceuticals Limited's promoter, Vupparapalli Chandrasekhar Reddy, increased their stake by 1.47 percentage points to 8.92%. This was achieved by converting 5.6 lakh warrants into equity shares through a preferential allotment on May 29, 2026.

Jun 03 2026 10:33:04

Novelix Pharmaceuticals Ltd - 536565 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Trimurthi's promoter group acquired 9.50 lakh equity shares through the conversion of warrants issued via preferential allotment on May 29, 2026. This transaction increased their absolute shareholding.

Jun 03 2026 10:30:47

Novelix Pharmaceuticals Ltd - 536565 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

Novelix Pharmaceuticals' promoter group increased its aggregate shareholding by 2.77%. This was achieved by acquiring 31.3 lakh equity shares through allotment following the conversion of warrants and a preferential offer.

Jun 02 2026 19:37:01

Novelix Pharmaceuticals Ltd - 536565 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Novelix Pharmaceuticals' promoter and promoter group entities, Srinidhi Fine-Chemicals LLP and Narahari Belide, were allotted 9.50 lakh equity shares through the conversion of warrants on a preferential basis on May 29, 2026. Their total holding stands at 36.42%.

Jun 02 2026 10:50:37

Novelix Pharmaceuticals Ltd - 536565 - Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On Thursday, 04Th June, 2026 Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

Trimurthi's Board of Directors will convene on June 04, 2026, to evaluate and potentially approve a preferential issue of securities. The meeting will also address the adoption of the EGM notice and setting its date for shareholder approval.

Jun 01 2026 20:41:20

Name	Position
Venkateshwarlu Pulluru	Whole Time Director
Janardhan Das Kabra	Non Executive Independent Director

Novelix Pharmaceuticals Similar Stocks

Race Eco Chain Ltd.

112.00

1.00 (0.90%)

Dhoot Industrial Finance Ltd.

231.00

0.75 (0.33%)

Parshva Enterprises Ltd.

188.00

0.00 (0.00%)

ABans Enterprises Ltd.

26.15

0.00 (0.00%)

Comfort Intech Ltd.

5.93

0.01 (0.17%)

B&A Packaging India Ltd.

179.00

0.00 (0.00%)

Waterbase Ltd.

44.50

0.02 (0.04%)

Anmol India Ltd.

11.23

-0.20 (1.75%)

Novelix Pharmaceuticals FAQs

Novelix Pharmaceuticals शेयर का खरीद मूल्य 77.07 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Novelix Pharmaceuticals शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Novelix Pharmaceuticals शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 0 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Novelix Pharmaceuticals शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 0 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Novelix Pharmaceuticals शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 2.27 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Novelix Pharmaceuticals का मार्केट कैप 141.29 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Novelix Pharmaceuticals शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 92.00 और 30.79 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।